Revance Therapeutics Inc (RVNC)

[soma2022]

Mark Foley Rule 10b5-1 Trading Arrangements. I was not aware that Mark Foley terminated his 10b5-1 late August. Don't think any of us saw this to be honest. Spoke to some securities attorneys about what is considered "in the clear" to buy back shares after terminating a 10b5-1 and they said 3 to 6 months although I see no real formal legal guidance.

The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September
30, 2023, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, were as follows:
Name and Title Action Date of Action Total Shares to be Sold Expiration Date
Mark Foley, Chief Executive Officer Terminate 8/28/23 442,576 5/31/2024
Olivia Ware, Director Adopt 8/31/23 9,593 8/30/2024
(1) Mr. Foley entered into this 10b5-1 Plan on March 10, 2023
During the three months ended September 30, 2023, none of our Section 16 officers or directors adopted or terminated a non-Rule 10b5-1 trading arrangement.
go to page 50: https://investors.revance.com/files/doc_financials/2023/q3/127ca7aa-db59-4fc9-a6f8-4392dbe6cf10.pdf